Anek Capital's Orel Levy's Cellebrite Thesis $CLBT

10 snips

Aug 1, 2025

Orel Levy, an investor at Anek Capital with a keen focus on value and event-driven opportunities, dives into the world of Cellebrite, a leader in digital forensics tools. He discusses the company's evolution into a SaaS model and its role in law enforcement. A shift in management, competitive threats like Palantir, and the integration of AI are thoroughly examined. Orel also unpacks the potential risks surrounding execution and possible M&A speculations, shedding light on Cellebrite's strategic positioning in a rapidly changing tech landscape.

Ask episode

AI Snips

Chapters

Transcript

Episode notes

INSIGHT

Cellebrite's R&D Moat

Cellebrite invests heavily in R&D to keep cracking phones despite constant OS security updates.
Customer trust builds a strong moat in this cat-and-mouse digital forensics game.

INSIGHT

Market Misunderstands Cellebrite

The market undervalued Cellebrite due to SPAC skepticism, transition pains, and management changes.
Misunderstandings around iPhone cracking capability also contributed to the depressed stock price.

INSIGHT

More Than Phone Cracking

Cellebrite's value goes beyond phone cracking; it analyzes vast structured and unstructured data.
Even if Apple or Google cooperated with law enforcement, Cellebrite's analytical capabilities remain essential.

Get the Snipd Podcast app to discover more snips from this episode

Get the app

In this episode of Yet Another Value Podcast, host Andrew Walker is joined by Orel Levy of Anek Capital to discuss Cellebrite (ticker: CLBT). The conversation explores Cellebrite’s digital forensics tools, from cracking phones to managing and analyzing data. Orel provides a comprehensive overview of Cellebrite's business model, competitive positioning, and potential for growth. Topics include their shift to a SaaS model, the federal sector's role, AI integration, competitive threats like Palantir, and the company’s broader strategic outlook. They also touch on risks, including execution challenges, management turnover, and potential M&A speculation. Tune in to understand why Cellebrite is at the intersection of technology, law enforcement, and investing.

If you're interested in the CLBT trata call mentioned during the podcast, see: https://www.trytrata.com/clbt____________________________________________________________

[00:00:00] Podcast intro and sponsor mention

[00:03:13] Cellebrite's history and pivot

[00:06:08] Phone cracking explained

[00:07:18] R&D moat and customer stickiness

[00:08:40] Valuation versus growth peers

[00:09:52] SPAC history and misunderstood model

[00:13:41] iPhone cracking and misconceptions[00:15:03] Apple, Google cooperation risk

[00:16:29] Growth potential and market size

[00:21:27] Management turnover and CEO plans

[00:27:38] Sale speculation and strategic fit

[00:30:49] Mission-critical usage example

[00:31:51] Federal budget and deployments

[00:33:52] Event-driven budget growth potential

[00:37:47] Guardian, Pathfinder, cloud ramping

[00:42:58] Long-term risks: execution concerns

[00:50:43] AI: neutral impact for now

[00:53:39] Suncorp ownership and sale pressure

[00:57:46] Ethics and private sector risks

[01:00:00] Wrap-up and future conversations

Links:If you're interested⁠ in the CLBT trata call mentioned during the podcast⁠, see: https://www.trytrata.com/clbt

Yet Another Value Blog: https://www.yetanothervalueblog.com

See our legal disclaimer here: https://www.yetanothervalueblog.com/p/legal-and-disclaimer